Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies
作者:Niggula Praveen Kumar、Pankaj Sharma、S. Sujana Kumari、Umarani Brahma、Shalini Nekkanti、Nagula Shankaraiah、Ahmed Kamal
DOI:10.1016/j.ejmech.2017.09.006
日期:2017.11
aldehydes with various substituted o-phenylenediamines. The title compounds were evaluated for their in vitro cytotoxic potential against various human cancer cell lines like breast (BT-549), prostate (PC-3 and DU145), triple negative breast cancer (MDA-MB-453), and human colon cancer (HCT-116 and HCT-15) cells. Among the tested compounds, 10o displayed significant in vitro cytotoxic activity against PC-3
Intramolecular Biaryl Oxidative Coupling of Stilbenes by Vanadium Oxytrichloride (VOCl<sub>3</sub>): Facile Synthesis of Substituted Phenanthrene Derivatives
作者:Zhong Jin、Qingmin Wang、Runqiu Huang
DOI:10.1081/scc-120027245
日期:2004.12.31
Abstract Vanadium oxytrichloride (VOCl3) has proven to be a highly efficient reagent for intramolecular biaryl oxidative coupling reaction of electron‐rich stilbenes. Accordingly, a mild and efficient route to phenanthrene derivatives from stilbenes oxygenated is developed.
A newseries of novel 1-phenanthryl-tetrahydroisoquinoline derivatives were designed, synthesized and biologically evaluated for their PAK4 inhibitory activities and anti-proliferative effects against three cancer cell lines A549, MCF-7 and HT-1080. Among them, compound 12a exhibited the most potent inhibitory activity against PAK4 with an IC50 value of 0.42 μM. Moreover, this compound inhibited the
Iron(III) chloride has been used to prepare polymethoxy-substituted phenanthrene-9-carboxylic acid via intramolecular oxidative coupling at room temperature in excellent yields. Mild reaction conditions and the use of environmentally friendly FeCl3 provide a novel practical route for the synthesis of the important phenanthrene ring. The further application of this protocol as the key step to total
A group of novel dibenzo[f,h]isoquinoline derivatives as shown in the specification. Also disclosed are methods of using the compounds for treating a disease associated with NO overproduction, cancer, or viral infection.